Reduction of oxidative stress marker levels by anti-TNF-alpha antibody, infliximab, in patients with rheumatoid arthritis.
Year: 2008
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: Y Kageyama, M Takahashi, T Ichikawa, E Torikai, A Nagano
Institutions: Hamamatsu University, Hamamatsu University School of Medicine
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2416322894
